| Literature DB >> 35645185 |
Aysu Yarman1,2, Sevinc Kurbanoglu3.
Abstract
Since the first reported case of COVID-19 in 2019 in China and the official declaration from the World Health Organization in March 2021 as a pandemic, fast and accurate diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has played a major role worldwide. For this reason, various methods have been developed, comprising reverse transcriptase-polymerase chain reaction (RT-PCR), immunoassays, clustered regularly interspaced short palindromic repeats (CRISPR), reverse transcription loop-mediated isothermal amplification (RT-LAMP), and bio(mimetic)sensors. Among the developed methods, RT-PCR is so far the gold standard. Herein, we give an overview of the MIP-based sensors utilized since the beginning of the pandemic.Entities:
Keywords: SARS-CoV-2; biomimetic sensors; molecularly imprinted polymers
Year: 2022 PMID: 35645185 PMCID: PMC9149885 DOI: 10.3390/biomimetics7020058
Source DB: PubMed Journal: Biomimetics (Basel) ISSN: 2313-7673
Figure 1Schematic representation of structural proteins of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and properties Reprinted with permission from Ref. [5]. 2021, MDPI.
Figure 2Workflow of MIP preparation Reprinted with permission from [20]. 2021, Elsevier.
Figure 3Schematic representation of structural levels of target analyte in the virus imprinting process.
MIP-based biomimetic sensors for SARS-CoV-2 detection.
| Template | Monomer | Transducer | Detection | (Linear) Range and LOD | Ref. |
|---|---|---|---|---|---|
| SARS-CoV-2 whole virus | 3-AP | CNT/WO3-SPCE | EIS | LOD: 57 pg/mL | [ |
| SARS-CoV-2 whole virus | NHMA MBAm (cross-linker) | SPE | EIS | 3–7 log10 pfu/mL LOD: 4.9 log10 pfu/mL | [ |
| SARS-CoV-2 whole virus | AAM, MAA, MMA, and NVP; DHEBA (cross-linker) | GO integrated Ag-SPE | CV | 0.01 fM to 100 fM LOD: 0.1 fM | [ |
| SARS-CoV-2 whole virus | Pyrrole; (graphene oxide) APBA (cross-linker); | GCE | DPV and amperometry | DPV: 0.74–9.03 fg mL–1 and LOD: 0.326 fg mL–1 | [ |
| SARS-CoV-2 nucleoprotein | m-PD | 4-ATP-modified Au-TFE | DPV | Up to 111 fM; LOD: 15 fM (in lysis buffer) | [ |
| SARS-CoV-2 nucleocapsid protein | Arginine | Au/Gr-modified SPCE | DPV | 10.0–200.0 fM; LOD: 3 fM | [ |
| SARS-CoV-2 spike protein | Pyrrole | Pt Electrode | CA | 0 μg/mL to 25 μg/mL | [ |
| SARS-CoV-2 RBD | o-PD | MP-Au-SPE | EIS | 2.0 pg·mL−1–40 pg·mL−1 LOD: 0.7 pg·mL−1 | [ |
| SARS-CoV-2 spike protein subunit S1 | APBA | 4-ATP-modified Au-TFME | SWV | LOD: 15 fM (in PBS) and 64 fM (patient’s nasopharyngeal samples) | [ |
| SARS-CoV-2 spike protein subunit S1 | Aam, TBAm, and HEMA; BIS (cross-Linker) | POF-based SPR chip | SPR | LOD: 0.058 µM | [ |
| SARS-CoV-2 spike protein RBD epitope (GFNCYFPLQ) | Scopoletin | Au- SPRi chips | SPR | NS | [ |
3-AP: 3-aminophenol; AAM: Acrylamide; APBA: 3-aminophenyl- boronic acid; Au-TFME: Thin-film Au metal electrodes, BIS: N,N′-methylene bisacrylamide; CA: Chronoamperometry; DHEBA: N,N′-(1,2-dihydroxy- ethylene) bisacrylamide; HEMA: 2-hydroxyethyl methacrylate; LOD: Limit of Detection; LOQ: Limit of Quantification; MAA: Methacrylic acid; MBAm: N,N′-methylenebisacrylamide; MMA: methyl methacrylate; m-PD: m-Phenylenediamine; NHMA: N-hydroxmethylacrylamide; NS: Not stated; NVP: N-vinylpyrrolidone; o-PD: o-Phenylenediamine; POF: Plasmonic Optical Fibers; SPCE: screen-printed carbon electrode; TBAm: N-t-butylacrylamide.
Figure 4Schematic representation of (a) the preparation of MIP-based sensor and (b) the electrochemical reduction of graphene oxide Reprinted with permission from [141]. 2022, Elsevier.
Figure 5Representation of the measurement in a redox marker solution upon the rebinding of the target analyte. Reprinted with permission from [65]. 2022, Elsevier.
Figure 6Schematic representation of steps of virus imprinting procedure preparation and the SPR responses of the rebinding Reprinted with permission from [82]. 2022, RSC.